/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

TALLAHASSEE, FL, May 15, 2019 /CNW/ - National cannabis company Trulieve Cannabis Corp. ("Trulieve" ‎or the "Company") (CSE: TRUL) announced that it has filed a (final) short form base ‎shelf prospectus with the securities regulatory authorities in each of the provinces of ‎Canada, other than the Province of Quebec.‎

The shelf prospectus is valid for a 25-month period, during which time Trulieve and certain of its security holders may qualify the distribution by way ‎of prospectus in Canada of up to $250 million of subordinate voting shares, debt securities, ‎warrants, subscription receipts, units, or any combination thereof of the Company from time to time, separately or together, in amounts, at prices and on terms to be determined based on market conditions at the time of the offering. The specific terms of any future offering will be established in a prospectus supplement to the shelf prospectus, which supplement will be filed with the applicable Canadian securities regulatory authorities. Unless otherwise specified in the prospectus supplement relating to a particular offering of securities, the net proceeds from any sale of any securities may be used by Trulieve for general corporate purposes, including funding ongoing operations and/or working capital requirements, to repay ‎indebtedness outstanding from time to time, for capital projects and potential future acquisitions. The Company will ‎not receive any proceeds from any sale of any Securities by the selling securityholders.

A copy of the (final) short form base shelf prospectus can be found on SEDAR at www.sedar.com.

About Trulieve

Trulieve Cannabis Corp. is a vertically integrated "seed to sale" company and is the first and ‎largest fully licensed cannabis company in the State of Florida. Trulieve cultivates and ‎produces all of its products in-house and distributes those products to Trulieve-branded ‎stores (dispensaries) throughout the State of Florida, as well as directly to patients via ‎home delivery. Trulieve also operates in California and Massachusetts.‎

Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL.‎

This press release does not constitute an offer to sell or a solicitation of an offer to buy nor ‎shall there be any sale of any of the securities in any jurisdiction in which such offer, ‎solicitation or sale would be unlawful. The securities have not been and will not be ‎registered under the United States Securities Act of 1933, as amended (the "U.S. Securities ‎Act"), or the securities laws of any state of the United States and may not be offered or sold ‎within the United States (as defined in Regulation S under the U.S. Securities Act) unless ‎registered under the U.S. Securities Act and applicable state securities laws or pursuant to ‎an exemption from such registration requirements.‎

Regarding Forward-Looking Information

This press release may contain forward-looking information that is based on certain ‎assumptions and involves known and unknown risks and uncertainties and other factors ‎that could cause actual events to differ materially from current assumptions and ‎expectations. These statements should not be read as guarantees of future performance or ‎results. Such statements involve known and unknown risks, uncertainties and other factors ‎that may cause actual results, performance or achievements to be materially different from ‎those implied by such statements. A more complete discussion of the risks and ‎uncertainties facing the Company appears in the Company's Annual Information Form and ‎continuous disclosure filings, which are available on SEDAR's website at www.sedar.com. ‎Readers are cautioned not to place undue reliance on these forward-looking statements, ‎which speak only as of the date of this press release. The Company disclaims any intention ‎or obligation, except to the extent required by law, to update or revise any forward-looking ‎statements as a result of new information or future events, or for any other reason.‎

SOURCE Trulieve Cannabis Corp.

For further information: Lynn Ricci, Director, Investor Relations, ‎(850) 270-5691, [email protected]; Victoria Walker, Director of Marketing & Community Relations, (704) 773-3446‎, [email protected]